Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study

Allison Martin*, Don E. Smith, Andrew Carr, Clare Ringland, Janaki Amin, Sean Emery, Jennifer Hoy, Cassy Workman, Nicholas Doong, Judith Freund, David A. Cooper

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

285 Citations (Scopus)

Fingerprint Dive into the research topics of 'Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study'. Together they form a unique fingerprint.

Medicine & Life Sciences